Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 11 of 319 for:    ibrutinib

Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma (iMYC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02884453
Recruitment Status : Recruiting
First Posted : August 31, 2016
Last Update Posted : September 18, 2019
Sponsor:
Collaborator:
Janssen, LP
Information provided by (Responsible Party):
Royal Marsden NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 30, 2021
Estimated Study Completion Date : December 30, 2021